Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GEP-NOC: [68Ga]-DOTANOC PET-CT in GEP-NETs
NCT02608203Phase 3Completed
- Sponsor
- Assistance Publique-Hôpitaux de Marseille
- Start
- May 2016
- Primary completion
- Jun 2019
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 3 trial of 68Ga-DOTANOC in gastroenteropancreatic neuroendocrine tumor (GEP-NET), sponsored by Assistance Publique-Hôpitaux de Marseille. Started May 2016; status: completed.
02
Drugs
68Ga-DOTANOC
03
Conditions
gastroenteropancreatic neuroendocrine tumor (GEP-NET)
Beyond the preview
Go deeper on NCT02608203.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02608203.